US 5,962,217 A · MSRV1 virus and MSRV2 pathogen and/or infective agent associated with multiple sclerosis, and biopolymer constituents thereof

Abstract

Composition including two pathogenic and/or infective agents associated with multiple sclerosis, namely a first agent which consists of a human virus possessing reverse transcriptase activity and related to a family of endogenous retroviral elements, or a variant of the virus, and a second agent, or a variant of the second agent, these two pathogenic and/or infective agents originating from the same viral strain chosen from the strains designated, respectively, POL-2 deposited with the ECACC on Jul. 22, 1992 under Accession Number V92072202 and MS7PG deposited with the ECACC on Jan. 8, 1993 under Accession Number V93010816, and from their variant strains.

Claims23

Dependent claims

An isolated or synthetic nucleotide fragment comprising a first nucleotide sequence selected from the group consisting of

SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO:12, SEQ ID NO:13, SEQ ID NO:14, SEQ ID NO:15, SEQ ID NO:27, SEQ ID NO:28, SEQ ID NO:29, SEQ ID NO:30, SEQ ID NO:34, SEQ ID NO:35, SEQ ID NO:36, SEQ ID NO:37,
a fragment of SEQ ID NO:12 comprising at least 100 contiguous monomers of SEQ ID NO:12, and
a complementary sequence complementary to one of said SEQ ID NO:10 through SEQ ID NO:15, SEQ ID NO:27 through SEQ ID NO:30, SEQ ID NO:34 through SEQ ID NO:37 or said fragment of SEQ ID NO:12.

Dependencies are inferred from the claim text.

MSRV1 virus and MSRV2 pathogen and/or infective agent associated with multiple sclerosis, and biopolymer constituents thereof

Life of this patent

MSRV1 virus and MSRV2 pathogen and/or infective agent associated with multiple sclerosis, and biopolymer constituents thereof

Life of this patent

Abstract

Claims23